CasadevallA, and PirofskiLA. The convalescent sera option for containing COVID-19. J Clin Invest, 2020; 130:1545–1548.
2.
DashP, Fiore-GartlandAJ, HertzT, et al.Quantifiable predictive features define epitope-specific T cell receptor repertoires. Nature, 2017; 547:89–93.
3.
JiangF, DengL, ZhangL, et al. Review of the clinical characteristics of Coronavirus Disease 2019 (COVID-19). J Gen Intern Med, 2020 [Epub ahead of print]; DOI: 10.1007/s11606-020-05762-w.
RudrarajuR, SurmanS, JonesB, et al.Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut. Virology, 2011; 410:429–436.
6.
SealyR, WebbyRJ, CrumptonJC, et al.Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccines. Int Immunol, 2013; 25:183–195.
7.
StavnezerJ, and SchraderCE. IgH chain class switch recombination: mechanism and regulation. J Immunol, 2014; 193:5370–5378.
8.
WangC, HorbyPW, HaydenFG, et al.A novel coronavirus outbreak of global health concern. Lancet, 2020; 395:470–473.
9.
Worldometer-real time world statistics, COVID-19 Coronavirus pandemic, www.worldometers.info (accessed March27, 2020).
